China's new COVID-19 treatment approved by 15 countries

0 Comment(s)Print E-mail China Daily, November 19, 2021
Adjust font size:

JS016, a new COVID-19 treatment with China's independent intellectual property, has been approved for emergency use by 15 countries, with the combination of another neutralizing antibody, CCTV News reported on Friday morning.

Currently, Phase 3 clinical trials of the neutralizing antibody medicine are being promoted actively in the country, according to the Chinese Academy of Sciences' Institute of Microbiology.

Its safety and efficacy in treating COVID-19 patients has been recognized, providing a new approach for the prevention and control of COVID-19 globally.

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:    
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter